ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Montelukast Intermediate Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-35F3537
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Montelukast Intermediate Market Insights Forecast to 2028
BUY CHAPTERS

Global Montelukast Intermediate Market Insights, Forecast to 2030

Code: QYRE-Auto-35F3537
Report
December 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
VIVAN Life Sciences
P.G. Shah & Co.
Manus Aktteva Biopharma
Ortin Laboratories

Montelukast Intermediate Market Size

The global Montelukast Intermediate market is projected to grow from US$ 5267 million in 2024 to US$ 6108.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.

Montelukast Intermediate Market

Montelukast Intermediate Market

Montelukast Intermediate is a leukotriene receptor antagonist (LTRA)
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines. Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers:
This report presents an overview of global market for Montelukast Intermediate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Montelukast Intermediate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Montelukast Intermediate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Montelukast Intermediate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Montelukast Intermediate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Montelukast Intermediate sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Montelukast Intermediate Market Report

Report Metric Details
Report Name Montelukast Intermediate Market
Accounted market size in 2024 US$ 5267 million
Forecasted market size in 2030 US$ 6108.1 million
CAGR 2.5
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • GMP
  • Non-GMP
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Manus Aktteva Biopharma, Ortin Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Montelukast Intermediate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Montelukast Intermediate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Montelukast Intermediate sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Montelukast Intermediate Market growing?

Ans: The Montelukast Intermediate Market witnessing a CAGR of 2.5 during the forecast period 2025-2030.

What is the Montelukast Intermediate Market size in 2030?

Ans: The Montelukast Intermediate Market size in 2030 will be US$ 6108.1 million.

Who are the main players in the Montelukast Intermediate Market report?

Ans: The main players in the Montelukast Intermediate Market are Manus Aktteva Biopharma, Ortin Laboratories

What are the Application segmentation covered in the Montelukast Intermediate Market report?

Ans: The Applications covered in the Montelukast Intermediate Market report are Asthma, Allergic Rhinitis, Bronchospasm, Urticaria

What are the Type segmentation covered in the Montelukast Intermediate Market report?

Ans: The Types covered in the Montelukast Intermediate Market report are GMP, Non-GMP

Recommended Reports

Pharmaceutical Intermediates

Allergy & Asthma Drugs

Respiratory Therapeutics

1 Study Coverage
1.1 Montelukast Intermediate Product Introduction
1.2 Market by Type
1.2.1 Global Montelukast Intermediate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market by Application
1.3.1 Global Montelukast Intermediate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Asthma
1.3.3 Allergic Rhinitis
1.3.4 Bronchospasm
1.3.5 Urticaria
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Montelukast Intermediate Sales Estimates and Forecasts 2019-2030
2.2 Global Montelukast Intermediate Revenue by Region
2.2.1 Global Montelukast Intermediate Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Montelukast Intermediate Revenue by Region (2019-2024)
2.2.3 Global Montelukast Intermediate Revenue by Region (2025-2030)
2.2.4 Global Montelukast Intermediate Revenue Market Share by Region (2019-2030)
2.3 Global Montelukast Intermediate Sales Estimates and Forecasts 2019-2030
2.4 Global Montelukast Intermediate Sales by Region
2.4.1 Global Montelukast Intermediate Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Montelukast Intermediate Sales by Region (2019-2024)
2.4.3 Global Montelukast Intermediate Sales by Region (2025-2030)
2.4.4 Global Montelukast Intermediate Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Montelukast Intermediate Sales by Manufacturers
3.1.1 Global Montelukast Intermediate Sales by Manufacturers (2019-2024)
3.1.2 Global Montelukast Intermediate Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Montelukast Intermediate in 2023
3.2 Global Montelukast Intermediate Revenue by Manufacturers
3.2.1 Global Montelukast Intermediate Revenue by Manufacturers (2019-2024)
3.2.2 Global Montelukast Intermediate Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Montelukast Intermediate Revenue in 2023
3.3 Global Key Players of Montelukast Intermediate, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Montelukast Intermediate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Montelukast Intermediate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Montelukast Intermediate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Montelukast Intermediate, Product Offered and Application
3.8 Global Key Manufacturers of Montelukast Intermediate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Montelukast Intermediate Sales by Type
4.1.1 Global Montelukast Intermediate Historical Sales by Type (2019-2024)
4.1.2 Global Montelukast Intermediate Forecasted Sales by Type (2025-2030)
4.1.3 Global Montelukast Intermediate Sales Market Share by Type (2019-2030)
4.2 Global Montelukast Intermediate Revenue by Type
4.2.1 Global Montelukast Intermediate Historical Revenue by Type (2019-2024)
4.2.2 Global Montelukast Intermediate Forecasted Revenue by Type (2025-2030)
4.2.3 Global Montelukast Intermediate Revenue Market Share by Type (2019-2030)
4.3 Global Montelukast Intermediate Price by Type
4.3.1 Global Montelukast Intermediate Price by Type (2019-2024)
4.3.2 Global Montelukast Intermediate Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Montelukast Intermediate Sales by Application
5.1.1 Global Montelukast Intermediate Historical Sales by Application (2019-2024)
5.1.2 Global Montelukast Intermediate Forecasted Sales by Application (2025-2030)
5.1.3 Global Montelukast Intermediate Sales Market Share by Application (2019-2030)
5.2 Global Montelukast Intermediate Revenue by Application
5.2.1 Global Montelukast Intermediate Historical Revenue by Application (2019-2024)
5.2.2 Global Montelukast Intermediate Forecasted Revenue by Application (2025-2030)
5.2.3 Global Montelukast Intermediate Revenue Market Share by Application (2019-2030)
5.3 Global Montelukast Intermediate Price by Application
5.3.1 Global Montelukast Intermediate Price by Application (2019-2024)
5.3.2 Global Montelukast Intermediate Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Montelukast Intermediate Market Size by Type
6.1.1 US & Canada Montelukast Intermediate Sales by Type (2019-2030)
6.1.2 US & Canada Montelukast Intermediate Revenue by Type (2019-2030)
6.2 US & Canada Montelukast Intermediate Market Size by Application
6.2.1 US & Canada Montelukast Intermediate Sales by Application (2019-2030)
6.2.2 US & Canada Montelukast Intermediate Revenue by Application (2019-2030)
6.3 US & Canada Montelukast Intermediate Market Size by Country
6.3.1 US & Canada Montelukast Intermediate Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Montelukast Intermediate Sales by Country (2019-2030)
6.3.3 US & Canada Montelukast Intermediate Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Montelukast Intermediate Market Size by Type
7.1.1 Europe Montelukast Intermediate Sales by Type (2019-2030)
7.1.2 Europe Montelukast Intermediate Revenue by Type (2019-2030)
7.2 Europe Montelukast Intermediate Market Size by Application
7.2.1 Europe Montelukast Intermediate Sales by Application (2019-2030)
7.2.2 Europe Montelukast Intermediate Revenue by Application (2019-2030)
7.3 Europe Montelukast Intermediate Market Size by Country
7.3.1 Europe Montelukast Intermediate Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Montelukast Intermediate Sales by Country (2019-2030)
7.3.3 Europe Montelukast Intermediate Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Montelukast Intermediate Market Size
8.1.1 China Montelukast Intermediate Sales (2019-2030)
8.1.2 China Montelukast Intermediate Revenue (2019-2030)
8.2 China Montelukast Intermediate Market Size by Application
8.2.1 China Montelukast Intermediate Sales by Application (2019-2030)
8.2.2 China Montelukast Intermediate Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Montelukast Intermediate Market Size by Type
9.1.1 Asia Montelukast Intermediate Sales by Type (2019-2030)
9.1.2 Asia Montelukast Intermediate Revenue by Type (2019-2030)
9.2 Asia Montelukast Intermediate Market Size by Application
9.2.1 Asia Montelukast Intermediate Sales by Application (2019-2030)
9.2.2 Asia Montelukast Intermediate Revenue by Application (2019-2030)
9.3 Asia Montelukast Intermediate Sales by Region
9.3.1 Asia Montelukast Intermediate Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Montelukast Intermediate Revenue by Region (2019-2030)
9.3.3 Asia Montelukast Intermediate Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Montelukast Intermediate Market Size by Type
10.1.1 Middle East, Africa and Latin America Montelukast Intermediate Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Montelukast Intermediate Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Montelukast Intermediate Market Size by Application
10.2.1 Middle East, Africa and Latin America Montelukast Intermediate Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Montelukast Intermediate Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Montelukast Intermediate Sales by Country
10.3.1 Middle East, Africa and Latin America Montelukast Intermediate Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Montelukast Intermediate Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Montelukast Intermediate Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 VIVAN Life Sciences
11.1.1 VIVAN Life Sciences Company Information
11.1.2 VIVAN Life Sciences Overview
11.1.3 VIVAN Life Sciences Montelukast Intermediate Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 VIVAN Life Sciences Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 VIVAN Life Sciences Recent Developments
11.2 P.G. Shah & Co.
11.2.1 P.G. Shah & Co. Company Information
11.2.2 P.G. Shah & Co. Overview
11.2.3 P.G. Shah & Co. Montelukast Intermediate Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 P.G. Shah & Co. Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 P.G. Shah & Co. Recent Developments
11.3 Manus Aktteva Biopharma
11.3.1 Manus Aktteva Biopharma Company Information
11.3.2 Manus Aktteva Biopharma Overview
11.3.3 Manus Aktteva Biopharma Montelukast Intermediate Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Manus Aktteva Biopharma Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Manus Aktteva Biopharma Recent Developments
11.4 Ortin Laboratories
11.4.1 Ortin Laboratories Company Information
11.4.2 Ortin Laboratories Overview
11.4.3 Ortin Laboratories Montelukast Intermediate Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Ortin Laboratories Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ortin Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Montelukast Intermediate Industry Chain Analysis
12.2 Montelukast Intermediate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Montelukast Intermediate Production Mode & Process
12.4 Montelukast Intermediate Sales and Marketing
12.4.1 Montelukast Intermediate Sales Channels
12.4.2 Montelukast Intermediate Distributors
12.5 Montelukast Intermediate Customers
13 Market Dynamics
13.1 Montelukast Intermediate Industry Trends
13.2 Montelukast Intermediate Market Drivers
13.3 Montelukast Intermediate Market Challenges
13.4 Montelukast Intermediate Market Restraints
14 Key Findings in The Global Montelukast Intermediate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
VIVAN Life Sciences
P.G. Shah & Co.
Manus Aktteva Biopharma
Ortin Laboratories
List of Tables
    Table 1. Global Montelukast Intermediate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of GMP
    Table 3. Major Manufacturers of Non-GMP
    Table 4. Global Montelukast Intermediate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Montelukast Intermediate Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Montelukast Intermediate Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Montelukast Intermediate Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Montelukast Intermediate Revenue Market Share by Region (2019-2024)
    Table 9. Global Montelukast Intermediate Revenue Market Share by Region (2025-2030)
    Table 10. Global Montelukast Intermediate Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Montelukast Intermediate Sales by Region (2019-2024) & (MT)
    Table 12. Global Montelukast Intermediate Sales by Region (2025-2030) & (MT)
    Table 13. Global Montelukast Intermediate Sales Market Share by Region (2019-2024)
    Table 14. Global Montelukast Intermediate Sales Market Share by Region (2025-2030)
    Table 15. Global Montelukast Intermediate Sales by Manufacturers (2019-2024) & (MT)
    Table 16. Global Montelukast Intermediate Sales Share by Manufacturers (2019-2024)
    Table 17. Global Montelukast Intermediate Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Montelukast Intermediate Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Montelukast Intermediate, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Montelukast Intermediate Price by Manufacturers 2019-2024 (USD/MT)
    Table 21. Global Montelukast Intermediate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Montelukast Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Intermediate as of 2023)
    Table 23. Global Key Manufacturers of Montelukast Intermediate, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Montelukast Intermediate, Product Offered and Application
    Table 25. Global Key Manufacturers of Montelukast Intermediate, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Montelukast Intermediate Sales by Type (2019-2024) & (MT)
    Table 28. Global Montelukast Intermediate Sales by Type (2025-2030) & (MT)
    Table 29. Global Montelukast Intermediate Sales Share by Type (2019-2024)
    Table 30. Global Montelukast Intermediate Sales Share by Type (2025-2030)
    Table 31. Global Montelukast Intermediate Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Montelukast Intermediate Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Montelukast Intermediate Revenue Share by Type (2019-2024)
    Table 34. Global Montelukast Intermediate Revenue Share by Type (2025-2030)
    Table 35. Montelukast Intermediate Price by Type (2019-2024) & (USD/MT)
    Table 36. Global Montelukast Intermediate Price Forecast by Type (2025-2030) & (USD/MT)
    Table 37. Global Montelukast Intermediate Sales by Application (2019-2024) & (MT)
    Table 38. Global Montelukast Intermediate Sales by Application (2025-2030) & (MT)
    Table 39. Global Montelukast Intermediate Sales Share by Application (2019-2024)
    Table 40. Global Montelukast Intermediate Sales Share by Application (2025-2030)
    Table 41. Global Montelukast Intermediate Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Montelukast Intermediate Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Montelukast Intermediate Revenue Share by Application (2019-2024)
    Table 44. Global Montelukast Intermediate Revenue Share by Application (2025-2030)
    Table 45. Montelukast Intermediate Price by Application (2019-2024) & (USD/MT)
    Table 46. Global Montelukast Intermediate Price Forecast by Application (2025-2030) & (USD/MT)
    Table 47. US & Canada Montelukast Intermediate Sales by Type (2019-2024) & (MT)
    Table 48. US & Canada Montelukast Intermediate Sales by Type (2025-2030) & (MT)
    Table 49. US & Canada Montelukast Intermediate Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Montelukast Intermediate Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Montelukast Intermediate Sales by Application (2019-2024) & (MT)
    Table 52. US & Canada Montelukast Intermediate Sales by Application (2025-2030) & (MT)
    Table 53. US & Canada Montelukast Intermediate Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Montelukast Intermediate Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Montelukast Intermediate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Montelukast Intermediate Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Montelukast Intermediate Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Montelukast Intermediate Sales by Country (2019-2024) & (MT)
    Table 59. US & Canada Montelukast Intermediate Sales by Country (2025-2030) & (MT)
    Table 60. Europe Montelukast Intermediate Sales by Type (2019-2024) & (MT)
    Table 61. Europe Montelukast Intermediate Sales by Type (2025-2030) & (MT)
    Table 62. Europe Montelukast Intermediate Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Montelukast Intermediate Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Montelukast Intermediate Sales by Application (2019-2024) & (MT)
    Table 65. Europe Montelukast Intermediate Sales by Application (2025-2030) & (MT)
    Table 66. Europe Montelukast Intermediate Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Montelukast Intermediate Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Montelukast Intermediate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Montelukast Intermediate Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Montelukast Intermediate Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Montelukast Intermediate Sales by Country (2019-2024) & (MT)
    Table 72. Europe Montelukast Intermediate Sales by Country (2025-2030) & (MT)
    Table 73. China Montelukast Intermediate Sales by Type (2019-2024) & (MT)
    Table 74. China Montelukast Intermediate Sales by Type (2025-2030) & (MT)
    Table 75. China Montelukast Intermediate Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Montelukast Intermediate Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Montelukast Intermediate Sales by Application (2019-2024) & (MT)
    Table 78. China Montelukast Intermediate Sales by Application (2025-2030) & (MT)
    Table 79. China Montelukast Intermediate Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Montelukast Intermediate Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Montelukast Intermediate Sales by Type (2019-2024) & (MT)
    Table 82. Asia Montelukast Intermediate Sales by Type (2025-2030) & (MT)
    Table 83. Asia Montelukast Intermediate Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Montelukast Intermediate Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Montelukast Intermediate Sales by Application (2019-2024) & (MT)
    Table 86. Asia Montelukast Intermediate Sales by Application (2025-2030) & (MT)
    Table 87. Asia Montelukast Intermediate Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Montelukast Intermediate Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Montelukast Intermediate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Montelukast Intermediate Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Montelukast Intermediate Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Montelukast Intermediate Sales by Region (2019-2024) & (MT)
    Table 93. Asia Montelukast Intermediate Sales by Region (2025-2030) & (MT)
    Table 94. Middle East, Africa and Latin America Montelukast Intermediate Sales by Type (2019-2024) & (MT)
    Table 95. Middle East, Africa and Latin America Montelukast Intermediate Sales by Type (2025-2030) & (MT)
    Table 96. Middle East, Africa and Latin America Montelukast Intermediate Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Montelukast Intermediate Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Montelukast Intermediate Sales by Application (2019-2024) & (MT)
    Table 99. Middle East, Africa and Latin America Montelukast Intermediate Sales by Application (2025-2030) & (MT)
    Table 100. Middle East, Africa and Latin America Montelukast Intermediate Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Montelukast Intermediate Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Montelukast Intermediate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Montelukast Intermediate Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Montelukast Intermediate Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Montelukast Intermediate Sales by Country (2019-2024) & (MT)
    Table 106. Middle East, Africa and Latin America Montelukast Intermediate Sales by Country (2025-2030) & (MT)
    Table 107. VIVAN Life Sciences Company Information
    Table 108. VIVAN Life Sciences Description and Major Businesses
    Table 109. VIVAN Life Sciences Montelukast Intermediate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. VIVAN Life Sciences Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. VIVAN Life Sciences Recent Developments
    Table 112. P.G. Shah & Co. Company Information
    Table 113. P.G. Shah & Co. Description and Major Businesses
    Table 114. P.G. Shah & Co. Montelukast Intermediate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. P.G. Shah & Co. Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. P.G. Shah & Co. Recent Developments
    Table 117. Manus Aktteva Biopharma Company Information
    Table 118. Manus Aktteva Biopharma Description and Major Businesses
    Table 119. Manus Aktteva Biopharma Montelukast Intermediate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Manus Aktteva Biopharma Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Manus Aktteva Biopharma Recent Developments
    Table 122. Ortin Laboratories Company Information
    Table 123. Ortin Laboratories Description and Major Businesses
    Table 124. Ortin Laboratories Montelukast Intermediate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. Ortin Laboratories Montelukast Intermediate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Ortin Laboratories Recent Developments
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Montelukast Intermediate Distributors List
    Table 130. Montelukast Intermediate Customers List
    Table 131. Montelukast Intermediate Market Trends
    Table 132. Montelukast Intermediate Market Drivers
    Table 133. Montelukast Intermediate Market Challenges
    Table 134. Montelukast Intermediate Market Restraints
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Montelukast Intermediate Product Picture
    Figure 2. Global Montelukast Intermediate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Montelukast Intermediate Market Share by Type in 2023 & 2030
    Figure 4. GMP Product Picture
    Figure 5. Non-GMP Product Picture
    Figure 6. Global Montelukast Intermediate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Montelukast Intermediate Market Share by Application in 2023 & 2030
    Figure 8. Asthma
    Figure 9. Allergic Rhinitis
    Figure 10. Bronchospasm
    Figure 11. Urticaria
    Figure 12. Montelukast Intermediate Report Years Considered
    Figure 13. Global Montelukast Intermediate Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Montelukast Intermediate Revenue 2019-2030 (US$ Million)
    Figure 15. Global Montelukast Intermediate Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Montelukast Intermediate Revenue Market Share by Region (2019-2030)
    Figure 17. Global Montelukast Intermediate Sales 2019-2030 ((MT)
    Figure 18. Global Montelukast Intermediate Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Montelukast Intermediate Sales YoY (2019-2030) & (MT)
    Figure 20. US & Canada Montelukast Intermediate Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Montelukast Intermediate Sales YoY (2019-2030) & (MT)
    Figure 22. Europe Montelukast Intermediate Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Montelukast Intermediate Sales YoY (2019-2030) & (MT)
    Figure 24. China Montelukast Intermediate Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Montelukast Intermediate Sales YoY (2019-2030) & (MT)
    Figure 26. Asia (excluding China) Montelukast Intermediate Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Montelukast Intermediate Sales YoY (2019-2030) & (MT)
    Figure 28. Middle East, Africa and Latin America Montelukast Intermediate Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Montelukast Intermediate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Montelukast Intermediate in the World: Market Share by Montelukast Intermediate Revenue in 2023
    Figure 31. Global Montelukast Intermediate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Montelukast Intermediate Sales Market Share by Type (2019-2030)
    Figure 33. Global Montelukast Intermediate Revenue Market Share by Type (2019-2030)
    Figure 34. Global Montelukast Intermediate Sales Market Share by Application (2019-2030)
    Figure 35. Global Montelukast Intermediate Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Montelukast Intermediate Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Montelukast Intermediate Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Montelukast Intermediate Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Montelukast Intermediate Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Montelukast Intermediate Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Montelukast Intermediate Sales Share by Country (2019-2030)
    Figure 42. U.S. Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Montelukast Intermediate Sales Market Share by Type (2019-2030)
    Figure 45. Europe Montelukast Intermediate Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Montelukast Intermediate Sales Market Share by Application (2019-2030)
    Figure 47. Europe Montelukast Intermediate Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Montelukast Intermediate Revenue Share by Country (2019-2030)
    Figure 49. Europe Montelukast Intermediate Sales Share by Country (2019-2030)
    Figure 50. Germany Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 51. France Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 55. China Montelukast Intermediate Sales Market Share by Type (2019-2030)
    Figure 56. China Montelukast Intermediate Revenue Market Share by Type (2019-2030)
    Figure 57. China Montelukast Intermediate Sales Market Share by Application (2019-2030)
    Figure 58. China Montelukast Intermediate Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Montelukast Intermediate Sales Market Share by Type (2019-2030)
    Figure 60. Asia Montelukast Intermediate Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Montelukast Intermediate Sales Market Share by Application (2019-2030)
    Figure 62. Asia Montelukast Intermediate Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Montelukast Intermediate Revenue Share by Region (2019-2030)
    Figure 64. Asia Montelukast Intermediate Sales Share by Region (2019-2030)
    Figure 65. Japan Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 69. India Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Montelukast Intermediate Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Montelukast Intermediate Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Montelukast Intermediate Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Montelukast Intermediate Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Montelukast Intermediate Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Montelukast Intermediate Sales Share by Country (2019-2030)
    Figure 76. Brazil Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Montelukast Intermediate Revenue (2019-2030) & (US$ Million)
    Figure 81. Montelukast Intermediate Value Chain
    Figure 82. Montelukast Intermediate Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Montelukast Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Montelukast Sodium Intermediates Market Research Report 2025
Global Pranlukast Market Research Report 2024
Global Zafirlukast API Market Research Report 2025
Zafirlukas Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tafluprost Market Insights Forecast to 2030
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030
Global H2 Antagonist Market Insights Forecast to 2030
Global TCR T Therapy Reagent Market Insights Forecast to 2030
Global Androgen Antagonist Market Insights Forecast to 2030
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030
Global GLP 1 Receptor Agonists Market Insights Forecast to 2030
LaCit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1R Agonist Market Insights Forecast to 2030
Global Montelukast Sodium Market Research Report 2025
Global LFA based Cardiac Marker Market Insights Forecast to 2030
Global Allergy EMR Software Market Insights Forecast to 2030
Drugs for Asthma and COPD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Montelukast Sodium Chewable Tablets Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions